tiprankstipranks
Sonnet BioTherapeutics Holdings (SONN)
NASDAQ:SONN
US Market

Sonnet BioTherapeutics Holdings (SONN) Cash flow

Compare
509 Followers

Sonnet BioTherapeutics Holdings Cash Flow

SONN's free cash flow for Q1 2025 was $-2.91M. For the 2025 fiscal year, SONN's free cash flow was decreased by $13.18M and operating cash flow was $-2.91M. See a summary of the company’s cash flow.
Cash Flow
Sep 24Sep 23Sep 22Sep 21Sep 20
Operating Cash Flow
$ -8.61M$ -21.34M$ -27.69M$ -22.55M$ -15.61M
Investing Cash Flow
$ -12.00K$ -443.25K$ -896.48K$ -3.62K$ -76.18K
Financing Cash Flow
$ 6.49M$ 21.01M$ 4.01M$ 42.83M$ 23.01M
End Cash Position
$ 149.46K$ 2.27M$ 3.05M$ 27.62M$ 7.35M
Free Cash Flow
$ -8.61M$ -21.79M$ -28.58M$ -22.56M$ -15.69M
Currency in USD

Sonnet BioTherapeutics Holdings Cash Flow

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis